āļŠāļēāļĢāļāļĢāļ°āļāļāļāļ§āļīāļāļąāļĒāđāļāļĢāļāđāļ āļŠāļąāļāļāļĢāļĢāļĄ
Buy sleep research peptides online â DSIP (Delta Sleep Inducing Peptide) and sleep-architecture modulators â at âĨ99% HPLC purity with full Certificate of Analysis. DSIP is a 9-amino-acid neuropeptide first isolated from rabbit cerebral venous blood during deep sleep, and it remains the most-studied peptide specifically targeting delta-wave (slow-wave) sleep architecture. Research applications cover sleep-stage modulation, circadian biology, stress-response research, and restorative-sleep biomarker studies. DSIP's mechanism remains incompletely understood in preclinical literature â which makes it a valuable research tool for exploring the molecular basis of sleep regulation. Each batch ships with batch-specific HPLC chromatogram, mass-spectrometry identity confirmation, and reconstitution guidance. Sleep research often stacks DSIP with recovery peptides (BPC-157, TB-500) in protocols studying post-exercise sleep and tissue-repair interaction.
DSIP (Delta Sleep Inducing Peptide) is the canonical research tool for delta-wave sleep-architecture studies. Originally isolated from cerebral venous blood of sleeping rabbits, it has been investigated for its capacity to modulate slow-wave sleep, stress-axis signaling (HPA), and pain thresholds in animal models.
Sleep-stage modulation intersects directly with tissue repair â most growth hormone release occurs during slow-wave sleep. Research protocols stacking DSIP with BPC-157 or TB-500 investigate whether enhanced sleep architecture accelerates post-exercise recovery.
DSIP research extends into HPA-axis modulation â cortisol rhythms, ACTH response, and stress-induced sleep disturbance models. Useful for research examining the overlap between chronic stress and sleep pathology.
DSIP's short half-life (~7 minutes in serum) means research protocols typically use timed-administration studies rather than chronic dosing. Well-suited for acute sleep-biomarker research rather than long-duration cohort studies.
Delta-wave (slow-wave) sleep architecture modulation is the primary research application. Secondary applications include stress-axis research, pain-threshold studies, and interaction studies with growth-hormone-releasing peptides.
No â DSIP is not a sedative in the benzodiazepine or GABAergic sense. It modulates sleep architecture (specifically slow-wave sleep) rather than inducing unconsciousness, which is why it remains a research tool of interest distinct from traditional sleep compounds.
Standard lyophilized-peptide protocol: reconstitute with bacteriostatic water, store at 2â8°C, use within 30 days. DSIP's short half-life means timing of injection relative to sleep onset is important for sleep-stage research protocols.
Showing 1â4 of 4 products
RecoveryFourNines
Delta Sleep-Inducing Peptide â āđāļāļāļēāđāļāļāđāļāļāđ 9 āļāļĢāļāļāļ°āļĄāļīāđāļ āļĻāļķāļāļĐāļēāđāļāļ·āđāļāļāļēāļĢāļŦāļĨāļąāļāļĨāļķāļ slow-wave āđāļĨāļ°āļāļēāļĢāļāļ§āļāļāļļāļĄāļāļąāļāļŦāļ§āļ°āļāļĩāļ§āļ āļēāļ
RecoveryFourNines
Ala-Glu-Asp-Gly tetrapeptide āļāļĩāđāđāļāđāļāļēāļāļŠāļēāļĢāļŠāļāļąāļāđāļāļĨāļĩāđāļāļāđāļāļāđāļāļēāļāļāđāļāļĄāđāļāđāļāļĩāļĒāļĨ â āļĻāļķāļāļĐāļēāđāļāļ·āđāļāļāļēāļĢāļāļĢāļ°āļāļļāđāļ telomerase āđāļĨāļ°āļāļĢāļąāļāļāļąāļāļŦāļ§āļ°āļāļĩāļ§āļ āļēāļ
ResearchWolf
Delta Sleep-Inducing Peptide â āđāļāļāļēāđāļāļāđāļāļāđ 9 āļāļĢāļāļāļ°āļĄāļīāđāļ āļĻāļķāļāļĐāļēāđāļāļ·āđāļāļāļēāļĢāļŦāļĨāļąāļāļĨāļķāļ slow-wave āđāļĨāļ°āļāļēāļĢāļāļ§āļāļāļļāļĄāļāļąāļāļŦāļ§āļ°āļāļĩāļ§āļ āļēāļ
RecoveryWolf
Ala-Glu-Asp-Gly tetrapeptide āļāļĩāđāđāļāđāļāļēāļāļŠāļēāļĢāļŠāļāļąāļāđāļāļĨāļĩāđāļāļāđāļāļāđāļāļēāļāļāđāļāļĄāđāļāđāļāļĩāļĒāļĨ â āļĻāļķāļāļĐāļēāđāļāļ·āđāļāļāļēāļĢāļāļĢāļ°āļāļļāđāļ telomerase āđāļĨāļ°āļāļĢāļąāļāļāļąāļāļŦāļ§āļ°āļāļĩāļ§āļ āļēāļ